Browsing by keyword "ENIGMA-Major Depressive Disorder Working Group"

Now showing items 1-2 of 2

    • Recovery Coaches in Opioid Use Disorder Care: Report and Estimator Tools
      London, Katharine; McCaffrey, Marybeth; McDowell, Lisa; Maughan, Matthew; Tourish, Jeremy (2019-01-24)
      An extensive report on the impacts recovery coach services can have on Opioid Use Disorder care in Massachusetts accompanied by two tools to assist in understanding how to develop such services. The report defines what a recovery coach is, delves into the role experts believe they could play in the recovery process and ultimately how they could change overall health outcomes. Along with the report, the team built a recovery coach Impact Estimator Tool which allows users to calculate the caseload, budgetary, financial, and clinical impact policy makers need before making the decision to invest in new forms of intervention. Implementing a new form of health care intervention requires research and planning. Finally, they created a Compendium of Recovery Coach Certification Requirements by State, which provides recovery coach certification information for 48 states and the District of Columbia. Client/Partner: RIZE Massachusetts

    • Substance Use Disorder Treatment in the Time of COVID
      Shanahan, Christopher W; Halpin, Susan M. (2021-01-28)
      Primary care clinicians face many challenges when addressing the complex needs of patients with chronic pain, substance use disorders or both. Over the last 10 months, the SARS-CoVID-2 pandemic has both increased and changed the challenges that healthcare providers face. Massachusetts Consultation Service for the Treatment of Addiction and Pain (MCSTAP) is a free service that helps doctors and other clinicians meet these challenges by increasing their capacity for, and comfort in, using evidence-based practices to screen, diagnose, treat and manage the care of these patients. MCSTAP provides on-demand physician consultation on safe prescribing and managing the care of patients with chronic pain and/or SUD. Join us for a webinar to learn about the innovative services that MCSTAP provides. Christopher Shanahan MD MPH FACP will share his knowledge about why and experience about how MCSTAP was created. You will learn about how SARS-CoVID-2 pandemic has changed SUD treatment and prescribing protocols. Currently, the SARS-CoVID-2 pandemic has presented serious and life-threatening challenges to both patients and to their clinicians. After attending this webinar, participants will: Understand the bidirectional relationship of SARS-Cov-2 pandemic & the epidemic U.S. Substance Use on identification & treatment of physical, mental health & Substance Use Disorders (SUD) e.g. opioid crisis Describe components & impact of Social Determinants of Health (SDOH) on care of individuals with SUD & impact on the risk for & clinical outcomes of SARS-CoV-2 infection Employ Intersectionality to identify/analyze key areas of need & potential for high impact & then develop/implement evidence-based & innovative solutions.